Payload Information
General Information of This Payload
Payload ID | PAY0KDKZT |
|||||
---|---|---|---|---|---|---|
Name | Quinoin |
|||||
Synonyms |
Quinoin
Click to Show/Hide
|
|||||
Target(s) | Receptor-interacting serine/threonine-protein kinase 1 (RIPK1) |
Each Antibody-drug Conjugate Related to This Payload
Full Information of The Activity Data of The ADC(s) Related to This Payload
Quinoin cetuximab immunoconjugate [Investigative]
Revealed Based on the Cell Line Data
Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
27.70 nM
|
Positive EGFR expression (EGFR +++/++) | ||
Method Description |
Cells were treated with different concentrations of drugs for 72 h. The viability was determined using the MTT assay.
|
||||
In Vitro Model | Colon carcinoma | GEO cells (Cetuximab-resistant) | CVCL_0271 |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.